These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8181908)

  • 1. Analysis of radiolabeled CHO cell-derived rHuGM-CSF pharmacokinetics and biodistribution in rhesus monkeys following intravenous and subcutaneous injection.
    Burchiel SW; Oette D; Day PW; Stoll RE
    Int J Immunopharmacol; 1994 Feb; 16(2):75-90. PubMed ID: 8181908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of single-dose administration of mammalian and bacterially-derived recombinant human granulocyte-macrophage colony-stimulating factor.
    Hovgaard D; Mortensen BT; Schifter S; Nissen NI
    Eur J Haematol; 1993 Jan; 50(1):32-6. PubMed ID: 8436212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetic studies of a human haemopoietic growth factor, GM-CSF.
    Hovgaard D; Mortensen BT; Schifter S; Nissen NI
    Eur J Clin Invest; 1992 Jan; 22(1):45-9. PubMed ID: 1559542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in leukopenic patients with advanced HIV disease.
    Manfredi R; Mastroianni A; Coronado O; Chiodo F
    J Chemother; 1996 Jun; 8(3):214-20. PubMed ID: 8808719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of dose and route of administration on the pharmacokinetics of granulocyte-macrophage colony-stimulating factor.
    Cebon JS; Bury RW; Lieschke GJ; Morstyn G
    Eur J Cancer; 1990; 26(10):1064-9. PubMed ID: 2148882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive immunotherapy with tumor-cytotoxic macrophages derived from recombinant human granulocyte-macrophage colony-stimulating factor (rhuGM-CSF) mobilized peripheral blood monocytes.
    Hennemann B; Rehm A; Kottke A; Meidenbauer N; Andreesen R
    J Immunother; 1997 Sep; 20(5):365-71. PubMed ID: 9336743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in children after intravenous and subcutaneous administration.
    Stute N; Furman WL; Schell M; Evans WE
    J Pharm Sci; 1995 Jul; 84(7):824-8. PubMed ID: 7562431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor.
    Kumar S; Villinger F; Oakley M; Aguiar JC; Jones TR; Hedstrom RC; Gowda K; Chute J; Stowers A; Kaslow DC; Thomas EK; Tine J; Klinman D; Hoffman SL; Weiss WW
    Immunol Lett; 2002 Apr; 81(1):13-24. PubMed ID: 11841841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of recombinant human colony stimulating factors (CSF) (granulocyte-macrophage CSF, granulocyte CSF, and CSF-1) on human monocyte/macrophage differentiation.
    Geissler K; Harrington M; Srivastava C; Leemhuis T; Tricot G; Broxmeyer HE
    J Immunol; 1989 Jul; 143(1):140-6. PubMed ID: 2471733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effects of recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF), alone and associated with zidovudine, on HIV-1 replication.
    Manfredi R; Re MC; Furlini G; Gorini R; Chiodo F
    New Microbiol; 1997 Oct; 20(4):345-50. PubMed ID: 9385605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor.
    Carlo-Stella C; Cazzola M; Bergamaschi G; Bernasconi P; Dezza L; Invernizzi R; Pedrazzoli P
    Leukemia; 1989 May; 3(5):363-6. PubMed ID: 2654496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
    Ahmad A; Laborada G; Bussel J; Nesin M
    Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.
    Tomer A; Stahl CP; McClure HM; Anderson DC; Myers LA; Liehl E; Winton EF
    Exp Hematol; 1993 Nov; 21(12):1577-82. PubMed ID: 8405239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial of recombinant human granulocyte-macrophage colony-stimulating factor derived from yeast in patients with breast cancer receiving cyclophosphamide, doxorubicin, and fluorouracil.
    O'Reilly SE; Gelmon KA; Onetto N; Parente J; Rubinger M; Page RA; Plenderleith IH
    J Clin Oncol; 1993 Dec; 11(12):2411-6. PubMed ID: 8246030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, tissue distribution and excretion of recombinant human parathyroid hormone 1-84 in animals.
    Bai H; Jing D; Jiang H; Yin S
    Cell Biochem Biophys; 2013 Jun; 66(2):379-87. PubMed ID: 23314825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
    Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary delivery of powders and solutions containing recombinant human granulocyte colony-stimulating factor (rhG-CSF) to the rabbit.
    Niven RW; Lott FD; Ip AY; Cribbs JM
    Pharm Res; 1994 Aug; 11(8):1101-9. PubMed ID: 7971709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory effects of human recombinant granulocyte-macrophage colony-stimulating factor (rhuGM-CSF): evidence of antitumour activity.
    Everly JJ; Lonial S
    Expert Opin Biol Ther; 2005 Mar; 5(3):293-311. PubMed ID: 15833068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human interleukin-3: pharmacokinetics after intravenous and subcutaneous bolus injection and effects on granulocyte kinetics.
    Hovgaard DJ; Folke M; Mortensen BT; Nissen NI
    Br J Haematol; 1994 Aug; 87(4):700-7. PubMed ID: 7986709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of varying doses of granulocyte-macrophage colony-stimulating factor on pharmacokinetics and antibody-dependent cellular cytotoxicity.
    Liljefors M; Nilsson B; Mellstedt H; Frödin JE
    Cancer Immunol Immunother; 2008 Mar; 57(3):379-88. PubMed ID: 17676322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.